The FDA has updated its shortage listings and enforcement posture around compounded semaglutide and tirzepatide. Here’s what that could mean for patients who rely on these medications for diabetes or weight management.
Federal regulators say current evidence does not show a clear link between GLP-1 weight-loss drugs and suicidal thoughts. Here’s what the FDA reviewed, what the data show, and what patients should watch for.
The 2025–2030 Dietary Guidelines for Americans place a stronger emphasis on health equity, cultural food patterns, and structural barriers to healthy eating. Here’s what that could mean for school meals, SNAP and WIC, healthcare settings, and everyday families.
The new 2025–2030 Dietary Guidelines for Americans are shaping school meals, SNAP benefits, and public health messaging nationwide. Here’s what they say about added sugar, sodium, and everyday eating—and how it affects heart disease and diabetes risk.
Federal health officials say the multistate infant botulism outbreak linked to ByHeart formula has ended. Here’s what happened, what symptoms parents should still watch for, and what to do if you have the recalled product at home.
Recent CDC cruise-ship outbreak reports highlight what really works against norovirus: soap and water, proper disinfection, and staying off the ship if you’re sick. Here’s what U.S. travelers should know before boarding.
CDC outbreak tracking shows active norovirus transmission this winter. Here’s what the current data suggest about this season—and the practical steps that reduce your risk at home, school, and work.
A practical guide for U.S. families on how maternal RSV vaccination during pregnancy and infant nirsevimab are reducing hospitalizations this 2025–2026 respiratory virus season.
For the 2025–2026 RSV season, CDC now routinely recommends a one-time RSV vaccine for adults 75 and older, and for adults 60–74 with certain risk factors. Here’s what changed, what the evidence shows, and what it means for Medicare coverage and access.
Finding bird flu genetic material in wastewater can sound alarming. Here’s what federal health agencies say those detections actually mean—and what they don’t—about everyday public-health risk in the United States.
The CDC continues to report human H5N1 bird flu cases linked mainly to dairy cattle and poultry exposure. Here’s what the latest updates show, why the overall public risk remains low, and why experts are closely watching for any sign of sustained person-to-person spread.
For the 2025–2026 flu season, U.S. vaccines protect against three strains instead of four. Here’s why public health experts dropped one influenza B lineage — and what that means for your family’s protection this year.
Flu activity remains elevated across much of the United States in mid-March 2026. Here’s what that means for families, older adults, and people with chronic conditions—and the practical steps that still make a difference.
As measles outbreaks expand in parts of the U.S. in 2026, some health departments are reporting measles virus detections in wastewater. Here’s what those signals mean, what they don’t, and how families should respond.
CDC surveillance shows rising U.S. measles cases in 2026. Here’s what that means for families, schools, and catch-up MMR vaccination—plus symptoms to watch for and when to seek care.
New federal funding from SAMHSA in 2026 aims to strengthen crisis response, expand community mental health services, and prevent suicide. Here’s what that could mean for families, schools, and local care access across the United States.
The 2026 Medicare physician fee schedule affects how doctors are paid, which services are prioritized, and how easy it may be for patients to find care. Here’s what the latest CMS updates could mean for access, preventive services, and community health.
Starting in 2026, new federal rules require many insurers to publicly report how often they deny, approve, or delay prior authorization requests. Here’s what that could mean for patients, doctors, and access to care.
Minnesota’s reported Medicaid funding deferral has raised questions about coverage stability, provider payments, and oversight. Here’s what enrollees and healthcare providers should understand now.
As the FDA updates its policies around compounded versions of GLP-1 drugs like semaglutide and tirzepatide, patients may see changes in availability, pricing, and oversight. Here’s what the shift means for access, safety, and insurance coverage.
The 2025–2030 Dietary Guidelines for Americans continue to shape school meals, SNAP, WIC, and everyday nutrition advice. Here’s how a stronger health-equity focus may influence policy, access, and practical food guidance across the United States.
The new 2025–2030 Dietary Guidelines for Americans reinforce practical steps for healthier eating. Here’s what changed, what stayed the same, and how the guidance may affect your daily meals, chronic disease risk, and long-term health.
End of content
End of content